Areas of focus
Approximately 1 in 8 women (13%) in the United States will develop breast cancer (BC) at some point in their life, making it the most common cancer diagnosed among women in the United States.3
With a deep understanding of the mechanism of the disease, and by listening and working with the patient community and those who care for them, we aspire to continue reimagining medicine for people touched by it.
Prostate cancer (PC) is the most common cancer among men, after skin cancer.4 At Novartis, we are focused on addressing the multi-faceted needs of people living with prostate cancer as they navigate this difficult disease.
Revolutionary therapies have transformed Chronic Myeloid Leukemia (CML), a type of blood cancer, into a chronic disease.5 However, many newly diagnosed patients do not meet their treatment goals and discontinue or change treatment due to intolerance.6 Patients need options that enable them to achieve meaningful outcomes while navigating a long-term, chronic illness.

Reimagining Cancer Care for the Next Generation Patient

The Novartis RLT Institute

Inspiring Generations to Prioritize their Breast Health

Novartis Joins First-of-Its-Kind Breast Cancer Policy Coalition

Advancing Prostate Cancer Care: A Bold New Partnership

Learn How Novartis is Connecting Patients to Pioneering Care at ASCO
Other therapeutic areas

Cardiovascular, renal and metabolic

Immunology

Neuroscience
References
- Jianhui Zhao, Liying Xu, Jing Sun. et al. BMJ Oncology. 2023. doi: 2:e000049.2
- Kadambi S, Loh KP, Dunne R. et al. Nat Rev Clin Oncol. 2020 Dec;17(12):742- 755. doi: 10.1038/s41571-020-0421-z
- American Cancer Society. 2024.
- American Cancer Society. Assessed June 27, 2024. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html.
- Novartis, 2021. Accessed September 6, 2023. http://www.novartis.com/news/novartis-hematology-relentless-pursuit-cure
- Claudiani S, Chughtai F, Khan A. et al. Leukemia. 2024;38:796 - 802. doi:10.1038/s41375-024-02187-w
- Christoph Soerensen SJ, Montez-Rath ME, Chung BI. et al. MP68-08 Journal of Urology. 2024; 211(5S):e1110. doi:10.1097/01.JU.0001008744.60568.e8.08